fashion -WSS

fashion

author：Wikipedia 2025-09-02 08:25:28 - browse：85922

Person wearing a blue glove holding money against a blue backdrop. — Adobe

WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday.

A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.

Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in the drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Average age of first period drops to 11.9 years, study shows

leisure time

focus

WSS

Addiction doctors spar with methadone clinics over legislation

Insmed lung disease drug hits target in key Phase 3 trial

Dark money group runs ads on China biotech bill

Do more moles mean more problems? Not so, says new study

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Prosthetic arm enables patients to feel the objects they grip

entertainment

fashion

hotspot

Medical records are filled with copy

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

At least 13 dead in Texas as scorching temps continue

FDA authorizes Novavax’s updated Covid

State Dept. review finds Biden bears some blame for Afghanistan failures

VC firm General Catalyst wants to buy a health system

Cancer drug shortages should be causing more outrage

Focused ultrasound for uterine fibroids: an uphill battle

As demand for Covid shots wanes, Moderna seeks its next success

Lab trade group sues FDA to halt regulation of lab

knowledge

Bristol 'take

FDA rejects Alnylam's heart disease treatment over insufficient data

Do more moles mean more problems? Not so, says new study

FDA authorizes Novavax’s updated Covid

3 questions for the future of Biden's cancer moonshot

Akili, maker of video game for ADHD, to be acquired for 34 million

focus

leisure time

focus

focus